CervoMed Secures $10.5 Million Private Placement to Advance Neflamapimod Development

CervoMed has entered into a definitive securities purchase agreement for a private placement expected to generate approximately $10.5 million in... Read More

The post CervoMed Secures $10.5 Million Private Placement to Advance Neflamapimod Development appeared first on citybiz.